Home NDC 60267-705 Sodium Thiosulfate
Product NDC 60267-705
11-digit product format 602670705
Labeler code 60267
Product ID 60267-705_4c4f587f-fb6f-4ce3-a09e-2a6a589b4d2b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Sodium Thiosulfate
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Hope Pharmaceuticals
Application NDA203923
Marketing category NDA
Marketing start 2012-02-14
Substance SODIUM THIOSULFATE
Active strength 250 mg/mL
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203923-001 SODIUM THIOSULFATE SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 N203923-001 12304813 2030-02-10 Drug product 2025-05-22 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N203923-001 SODIUM THIOSULFATE 12.5GM/50ML (250MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-02-14 f41ea6bd6efb…
Observed Orange Book patent history# Patent history page 1 of 5 · 187 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N203923-001 12304813 2030-02-10 Drug product 2025-05-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N203923-001 12304813 2030-02-10 Drug product 2025-05-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203923-001 12304813 2030-02-10 Drug product 2025-05-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 12304813 2030-02-10 Drug product 2025-05-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203923-001 12304813 2030-02-10 Drug product 2025-05-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203923-001 11753301 2030-02-10 U-3682 Drug substance, Drug product 2023-09-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203923-001 10479686 2030-07-07 U-3390 Drug product 2022-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203923-001 9345724 2030-07-07 U-2015 Drug substance, Drug product 2017-06-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203923-001 9585912 2030-07-07 Drug substance, Drug product 2017-06-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203923-001 8496973 2031-03-29 U-1419 Drug substance, Drug product 2013-08-02 b8a1b40f171c…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Sodium Thiosulfate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SODIUM THIOSULFATE 250 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination HX1032V43M Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 237832 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60267-705-50 Sodium Thiosulfate 50 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 50 15 60267-705-50 NITHIODOTE 50 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 50 mL 250 mg in 1mL 10
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60267-705 SODIUM THIOSULFATE INJECTION, SOLUTION [HOPE PHARMACEUTICALS] 13 Current NDC, Legacy NDC, 1 package rows 20241228_82f55408-2de9-463d-85e8-b39c3b259f0b.zip 60267-705 NITHIODOTE (SODIUM NITRITE AND SODIUM THIOSULFATE) KIT [HOPE PHARMACEUTICALS] 9 Current NDC, Legacy NDC 20241228_ff4941b3-9901-4aab-adcf-c5327bede34e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 60267-705-50 60267070550 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50) 50 ml 2012-02-14 0000-00-00 No No Current